ACQUIRED POROKERATOSIS

This adverse event was reported 29 times

ACQUIRED POROKERATOSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ETOPOSIDE PHOSPHATE 1 0.0006
1 BLEOMYCIN SULFATE 3 0.0003
2 ANASTROZOLE TABLETS 6 0.0003
3 ELBASVIR AND GRAZOPREVIR 1 0.0002
4 ANASTROZOLE 6 0.0002
5 RISEDRONATE SODIUM 3 0.0001
6 TEMOZOLOMIDE 2 0.0001
7 TOFACITINIB CITRATE 1 0.0001
8 ERGOCALCIFEROL 2 0.0001
9 TACROLIMUS OINTMENT 0.1% 8 0.0001
See all drugs enriched for association with ACQUIRED POROKERATOSIS